Fondazione Toscana Life Sciences

Fondazione Toscana Life Sciences is a research organisation in Siena, Italy that has taken part in 20 EU-funded projects since 2009, receiving €14.5M in EU funding and leading 4 as coordinator.

EU funding received€14.5M
EU projects20
As coordinator4
Running now9
First EU project2009
Latest project2026
CountryItaly
EU registration (PIC)998436424
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fondazione Toscana Life Sciences's own share of each project, not the project's full budget.

  • Horizon Europe€8.1M · 9 projects
  • Horizon 2020€5.5M · 7 projects
  • FP7 (2007 to 2013)€762k · 3 projects
  • Programme for the Competitiveness of Enterprises and small and medium-sized enterprises€60k · 1 project

Projects

20 EU-funded projects, newest first. Fondazione Toscana Life Sciences led 4 of them as coordinator. Each links to the official record.

  • GLIOGEN-XPartner

    From Magnetic Resonance Imaging to Molecular Signatures: Generative AI for Virtual Biopsy in Gliomas

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €710ktheir share
  • TRANSCAN-4Partner

    TRANSCAN-4 : Sustained collaboration of funders to support Cancer translational research

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €97ktheir share
  • IMMUFELLOWAssociated partner

    Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • OHAMRPartner

    European Partnership One Health AntiMicrobial Resistance

    Horizon Europe · 2025–2035 · Project on CORDIS ↗

    €100ktheir share
  • ArTCellPartner

    Bottom-up manufacturing of artificial anti-tumor T cells

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €547ktheir share
  • PROACTIVECoordinator

    PROposing Action to ConTrol and Impede betacoronaVirus Emergencies

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €2.5Mtheir share
  • EP PerMedPartner

    European Partnership for Personalised Medicine

    Horizon Europe · 2023–2033 · Project on CORDIS ↗

    €712ktheir share
  • IMPACT- AMLPartner

    Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €329ktheir share
  • MammoScreenCoordinator

    Innovative and safe microwave-based imaging technology to make breast cancer screening more accurate, inclusive and female-friendly

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €3.1Mtheir share
  • BornToGetTherePartner

    Implementation of early detection and early intervention service delivery in infants at risk for cerebral palsy to promote infants’ psychomotor development and maternal health

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €430ktheir share
  • SINO-EU-PerMedPartner

    Widening Sino‐EU policy and research cooperation in Personalised Medicine

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €430ktheir share
  • VACCIBIOMEPartner

    Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €1.5Mtheir share
  • vAMResCoordinator

    Vaccines as a remedy for antimicrobial resistant bacterial infections

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €2.4Mtheir share
  • REGIONS4PERMEDCoordinator

    INTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTH

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €702ktheir share
  • AI4DiagPartner

    Strategic Cluster Partnership for increased competitiveness of European Medical Diagnostics SMEs thanks to Artificial Intelligence

    Programme for the Competitiveness of Enterprises and small and medium-sized enterprises · 2018–2020 · Project on the EU portal ↗

    €60ktheir share
  • OMVCRCPartner

    Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy

    Horizon 2020 · 2018–2019 · Project on CORDIS ↗

    €56ktheir share
  • TRANSCAN-2Associated partner

    ERA-NET: Aligning national/regional translational cancer research programmes and activities

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

  • OMVACPartner

    Outer Membrane Vesicles (OMVs) from “Vaccinobacter”: A Synthetic Biology approach for effective vaccines against infectious diseases and cancer

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €497ktheir share
  • NERRIPartner

    Neuro-Enhancement: Responsible Research and Innovation

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €147ktheir share
  • EPISODEPartner

    Exploiting the Potential of Structural Biology through NMR and Associated Technologies - Opportunities for Economic Development of Pharma/Biotech in Tuscany, Berlin-Brandenburg and Beyond

    FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗

    €118ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotic resistance
  • antibiotics
  • civil society
  • colorectal cancer
  • confocal microscopy
  • coronaviruses
  • drug discovery
  • epidemiology
  • governance
  • health care sciences
  • health economics
  • humanities
  • immunisation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime